This paper presents a new method for discriminating centroblast (CB) from non-centroblast cells in microscopic images acquired from tissue biopsies of follicular lymphoma. In the proposed method tissue sections are sliced at a low thickness level, around 1-1.5 μm, which provides a more detailed depiction of the nuclei and other textural information of cells usually not distinguishable in thicker specimens, such as 4-5 μm, that have been used in the past by other researchers. To identify CBs, a morphological and textural analysis is applied in order to extract various features related to their nuclei, nucleoli and cytoplasm. The generated feature vector is then used as input in a two-class SVM classifier with ε-Support Vector Regression and radial basis kernel function. Experimental results with an annotated dataset consisting of 300 images of centroblasts and non-centroblasts, derived from high-power field images of follicular lymphoma stained with Hematoxylin and Eosin, have shown the great potential of the proposed method with an average detection rate of 97.44%.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/EMBC.2014.6944346 | DOI Listing |
Cureus
December 2024
Musculoskeletal Radiology, Fleury Group, São Paulo, BRA.
Follicular lymphoma (FL) is an indolent non-Hodgkin lymphoma subtype, posing challenges in prognostication. While interim PET/CT is a recognized response assessment tool in other lymphoma subtypes, its prognostic value for FL remains uncertain. This study aims to evaluate the significance of interim PET results, which were assessed using the Deauville Score.
View Article and Find Full Text PDFAm J Surg Pathol
January 2025
Department of Pathology, University Hospital Henri Mondor, AP-HP, Créteil, France.
Lymphomas of T-follicular helper origin (T-follicular helper-cell lymphoma [TFHL]) are often accompanied by an expansion of B-immunoblasts, occasionally with Hodgkin/Reed-Sternberg-like (HRS-like) cells, making the differential diagnosis with classic Hodgkin lymphoma (CHL) difficult. We compared the morphologic, immunophenotypic, and molecular features of 15 TFHL and 12 CHL samples and discussed 4 challenging cases of uncertain diagnosis. Compared with CHL, TFHL disclosed more frequent sparing of subcortical sinuses, high-endothelium venule proliferation, dendritic cell meshwork expansion, T-cell atypia, and aberrant T-cell immunophenotype.
View Article and Find Full Text PDFIntroduction: Anal Lymphoma (AL) is a rare presentation of extranodal lymphomas, characterized by occurrence in the anal area and largely understudied due to its infrequency. This study aims to address gaps in knowledge about AL's demographic and clinical profiles, treatments, and survival outcomes, leveraging data from the SEER program.
Methods: We conducted a retrospective analysis of 79 AL cases identified in the SEER database from 2000 to 2022; 36 stage I AL were identified and defined as localized primary anal lymphoma (L-PAL).
Leuk Lymphoma
January 2025
Memorial Sloan Kettering Cancer Center, New York, New York, United States.
Follicular lymphoma (FL) represents the second most frequent type of non-Hodgkin lymphoma and the most common indolent histology. The disease course of FL is heterogeneous, likely resulting from diverse molecular and immunological features that drive a broad spectrum of clinical presentations. While some patients with low-volume and asymptomatic disease are suitable for observation, patients with high tumor burden, advanced-stage, or symptomatic disease more often necessitate treatment initiation.
View Article and Find Full Text PDFBiomark Res
January 2025
Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361003, P.R. China.
Background: Disease progression within 24 months (POD24) significantly impacts overall survival (OS) in patients with follicular lymphoma (FL). This study aimed to develop a robust predictive model, FLIPI-C, using a machine learning approach to identify FL patients at high risk of POD24.
Methods: A cohort of 1,938 FL patients (FL1-3a) from seventeen centers nationwide in China was randomly divided into training and internal validation sets (2:1 ratio).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!